BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24046114)

  • 21. Predictors of margin status after breast-conserving operations in an underscreened population.
    Torabi R; Hsu CH; Patel PN; Dave H; Bouton ME; Komenaka IK
    Langenbecks Arch Surg; 2013 Mar; 398(3):455-62. PubMed ID: 23184267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraoperative Assessment of Final Margins with a Handheld Optical Imaging Probe During Breast-Conserving Surgery May Reduce the Reoperation Rate: Results of a Multicenter Study.
    Zysk AM; Chen K; Gabrielson E; Tafra L; May Gonzalez EA; Canner JK; Schneider EB; Cittadine AJ; Scott Carney P; Boppart SA; Tsuchiya K; Sawyer K; Jacobs LK
    Ann Surg Oncol; 2015 Oct; 22(10):3356-62. PubMed ID: 26202553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extent of margin involvement, lymphovascular invasion, and extensive intraductal component predict for residual disease after wide local excision for breast cancer.
    Alrahbi S; Chan PM; Ho BC; Seah MD; Chen JJ; Tan EY
    Clin Breast Cancer; 2015 Jun; 15(3):219-26. PubMed ID: 25576998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients.
    Mukhtar RA; Wong J; Piper M; Zhu Z; Fahrner-Scott K; Mamounas M; Sbitany H; Alvarado M; Foster R; Ewing C; Esserman L
    Ann Surg Oncol; 2018 Oct; 25(11):3165-3170. PubMed ID: 30054826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility Study of a Novel Protease-Activated Fluorescent Imaging System for Real-Time, Intraoperative Detection of Residual Breast Cancer in Breast Conserving Surgery.
    Smith BL; Lanahan CR; Specht MC; Kelly BN; Brown C; Strasfeld DB; Ferrer JM; Rai U; Tang R; Rice-Stitt T; Biernacka A; Brachtel EF; Gadd MA
    Ann Surg Oncol; 2020 Jun; 27(6):1854-1861. PubMed ID: 31898104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.
    Freedman G; Fowble B; Hanlon A; Nicolaou N; Fein D; Hoffman J; Sigurdson E; Boraas M; Goldstein L
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1005-15. PubMed ID: 10421533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resection of Cavity Shave Margins in Stage 0-III Breast Cancer Patients Undergoing Breast Conserving Surgery: A Prospective Multicenter Randomized Controlled Trial.
    Dupont E; Tsangaris T; Garcia-Cantu C; Howard-McNatt M; Chiba A; Berger AC; Levine EA; Gass JS; Gallagher K; Lum SS; Martinez RD; Willis AI; Pandya SV; Brown EA; Fenton A; Mendiola A; Murray M; Solomon NL; Senthil M; Ollila DW; Edmonson D; Lazar M; Namm JP; Li F; Butler M; McGowan NE; Herrera ME; Avitan YP; Yoder B; Walters LL; McPartland T; Chagpar AB
    Ann Surg; 2021 May; 273(5):876-881. PubMed ID: 31290763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does Preoperative MRI Reduce Positive Margins after Breast-Conserving Surgery?
    Cairns A; Chagpar AB; Dupont E; Levine EA; Gass JS; Chiba A; Ollila DW; Howard-McNatt M;
    Ann Surg Oncol; 2023 Oct; 30(10):6053-6058. PubMed ID: 37505353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.
    Smitt MC; Horst K
    Ann Surg Oncol; 2007 Mar; 14(3):1040-4. PubMed ID: 17203329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Breast Density Increase the Risk of Re-excision for Women with Breast Cancer Having Breast-Conservation Therapy?
    Walsh SM; Brennan SB; Zabor EC; Rosenberger LH; Stempel M; Lebron-Zapata L; Gemignani ML
    Ann Surg Oncol; 2019 Dec; 26(13):4246-4253. PubMed ID: 31396783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does intra-operative margin assessment improve margin status and re-excision rates? A population-based analysis of outcomes in breast-conserving surgery for ductal carcinoma in situ.
    Laws A; Brar MS; Bouchard-Fortier A; Leong B; Quan ML
    J Surg Oncol; 2018 Dec; 118(7):1205-1211. PubMed ID: 30293241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive Nipple Margin After Nipple-Sparing Mastectomy: An Alternative and Oncologically Safe Approach to Preserving the Nipple-Areolar Complex.
    Haslinger ML; Sosin M; Bartholomew AJ; Crocker A; Gulla A; Willey SC; Pittman TA; Tousimis EA
    Ann Surg Oncol; 2018 Aug; 25(8):2303-2307. PubMed ID: 29905891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy.
    Schnitt SJ; Abner A; Gelman R; Connolly JL; Recht A; Duda RB; Eberlein TJ; Mayzel K; Silver B; Harris JR
    Cancer; 1994 Sep; 74(6):1746-51. PubMed ID: 8082077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of routine cavity shave margins on breast cancer re-excision rates.
    Kobbermann A; Unzeitig A; Xie XJ; Yan J; Euhus D; Peng Y; Sarode V; Moldrem A; Marilyn Leitch A; Andrews V; Stallings C; Rao R
    Ann Surg Oncol; 2011 May; 18(5):1349-55. PubMed ID: 21046260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of Residual Tumor in Breast-Conserving Therapy.
    Rath MG; Uhlmann L; Heil J; Domschke C; Roth Z; Sinn HP; Marme F; Scharf A; Schneeweiss A; Kieser M; Sohn C; Rom J
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S451-8. PubMed ID: 26224405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence-Guided System: A Nonrandomized Controlled Trial.
    Hwang ES; Beitsch P; Blumencranz P; Carr D; Chagpar A; Clark L; Dekhne N; Dodge D; Dyess DL; Gold L; Grobmyer S; Hunt K; Karp S; Lesnikoski BA; Wapnir I; Smith BL;
    JAMA Surg; 2022 Jul; 157(7):573-580. PubMed ID: 35544130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy.
    Gage I; Schnitt SJ; Nixon AJ; Silver B; Recht A; Troyan SL; Eberlein T; Love SM; Gelman R; Harris JR; Connolly JL
    Cancer; 1996 Nov; 78(9):1921-8. PubMed ID: 8909312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Consensus Guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on Margins for Breast-Conserving Surgery in Stages 1 and 2 Invasive Breast Cancer.
    Chung A; Gangi A; Amersi F; Bose S; Zhang X; Giuliano A
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S422-7. PubMed ID: 26310280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low re-excision rate for positive margins in patients treated with ultrasound-guided breast-conserving surgery.
    Yu CC; Chiang KC; Kuo WL; Shen SC; Lo YF; Chen SC
    Breast; 2013 Oct; 22(5):698-702. PubMed ID: 23333255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Margin width should not still enforce a systematic surgical re-excision in the conservative treatment of early breast infiltrative ductal carcinoma.
    Jaffré I; Campion L; Dejode M; Bordes V; Sagan C; Loussouarn D; Dravet F; Andrieux N; Classe JM
    Ann Surg Oncol; 2013 Nov; 20(12):3831-8. PubMed ID: 23838905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.